Peptides in DNA delivery: current insights and future directions

Drug Discovery Today

Volumn 13, Issue 3-4, 2008, Pages 152-160

  Mann, Anita ^a   Thakur, Garima ^a   Shukla, Vasundhara ^a   Ganguli, Munia ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN; DNA; GLYCYLALANYLLEUCYLPHENYLALANYLLEUCYLGLYCYLPHENYLALANYLLEUCYL GLYCYLALANYLALANYLGLYCYLSERYLTHREONYLMETHIONYLGLYCYLALANYLTRYPTOPHYLSERYL GLUTAMINYLPROLYLLYSYLSERYLLYSYLARGINYLLYSYLVALINE; GLYCYLISOLEUCYLGLYCYLALANYLVALYLLEUCYLLYSYLVALYLLEUCYLTHREONYL THREONYLGLYCYLLEUCYLPROLYLALANYLLEUCYLISOLEUCYLSERYLTRYPTOPHYLISOLEUCYL LYSYLARGINYLLYSYLARGINYLGLUTAMINYLGLUTAMINE; GLYCYLLEUCYLPHENYLALANYLARGINYLALANYLLEUCYLLEUCYLARGINYLLEUCYL LEUCYLARGINYLSERYLLEUCYLTHREONYLALANYLLEUCYLLEUCYLLEUCYLARGINYLALANINE; GLYCYLLEUCYLPHENYLALANYLGLUTAMYLALANYLISOLEUCYLALANYLGLYCYL PHENYLALANYLISOLEUCYLGLUTAMYLASPARAGINYLGLYCYLTRYPTOPHYLGLUTAMYL GLYCYLMETHIONYLISOLEUCYLASPARTYLGLYCINE; GLYCYLLEUCYLPHENYLALANYLGLUTAMYLALANYLLEUCYLLEUCYL GLUTAMYLLEUCYLLEUCYLGLUTAMYLSERYLLEUCYLTRYPTOPHYLGLUTAMYLLEUCYLLEUCYL GLUTAMYLALANINE; GLYCYLLEUCYLPHENYLALANYLHISTIDYLALANYLISOLEUCYLALANYLHISTIDYL PHENYLALANYLISOLEUCYLHISTIDYLGLYCYLGLYCYLTRYPTOPHYLHISTIDYLGLYCYL LEUCYLISOLEUCYLHISTIDYLGLYCYLTRYPTOPHYLTYROSYLGLYCINE; GLYCYLLEUCYLPHENYLALANYLLYSYLALANYLISOLEUCYLALANYL GLUTAMYLPHENYLALANYLISOLEUCYLGLUTAMYLGLYCYLGLYCYLTRYPTOPHYLGLUTAMYL GLYCYLLEUCYLISOLEUCYLGLUTAMYLGLYCINE; GLYCYLLEUCYLPHENYLALANYLLYSYLALANYLISOLEUCYLALANYLGLUTAMYL PHENYLALANYLISOLEUCYLGLUTAMYLGLYCYLGLYCYLTRYPTOPHYLGLUTAMYLGLYCYL LEUCYLISOLEUCYLGLUTAMYLGLYCYLCYSTEINYLALANINE; GLYCYLLEUCYLPHENYLALANYLLYSYLALANYLISOLEUCYLALANYLGLUTAMYL PHENYLALANYLISOLEUCYLGLUTAMYLGLYCYLGLYCYLTRYPTOPHYLGLUTAMYLGLYCYL LEUCYLISOLEUCYLGLUTAMYLGLYCYLTRYPTOPHYLTYROSYLGLYCINE; GLYCYLLEUCYLPHENYLALANYLLYSYLALANYLISOLEUCYLALANYLLYSYL PHENYLALANYLISOLEUCYLLYSYLGLYCYLGLYCYLTRYPTOPHYLLYSYLGLYCYL LEUCYLISOLEUCYLLYSYLGLYCINE; GLYCYLLEUCYLPHENYLALANYLLYSYLALANYLLEUCYLLEUCYLLYSYLLEUCYLLEUCYL LYSYLSERYLLEUCYLTHREONYLLYSYLLEUCYLLEUCYLLEUCYLLYSYLALANINE; METHIONYLARGINYLARGINYLALANYLHISTIDYLHISTIDYLARGINYLARGINYL ARGINYLARGINYLALANYLSERYLHISTIDYLARGINYLARGINYLMETHIONYLARGINYLGLYCYLGLYCINE; OLIGONUCLEOTIDE; PENETRATIN; PEPTIDE; PROTEIN VP22; REV PROTEIN; TRANSACTIVATOR PROTEIN; TRANSPORTAN; TRANSPORTAN 10; UNCLASSIFIED DRUG;

CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DNA PROTEIN COMPLEX; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG STRUCTURE; GENE TARGETING; HUMAN; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MEMBRANE DAMAGE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PH; REVIEW;

AMINO ACID SEQUENCE; DNA; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GENETIC VECTORS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 39149119628     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2007.11.008     Document Type: Review

References (63)

1. Edelstein, M.L. et al. (2007) Gene therapy clinical trials worldwide to 2007-an update. J. Gene Med. 10.1002/jgm.1100
2. Luo D., and Saltzman W.M. Synthetic DNA delivery systems. Nat. Biotechnol. 18 (2000) 33-37
3. Fabre J.W., and Collins L. Synthetic peptides as non-viral DNA vectors. Curr. Gene Ther. 6 (2006) 459-480
4. Gottschalk S., et al. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther. 3 (1996) 48-57
5. McKenzie D.L., et al. Comparative gene transfer efficiency of low molecular weight polylysine DNA condensing peptides. J. Peptide Res. 54 (1999) 311-318
6. Adami R.C., et al. Stability of the peptide-condensed plasmid DNA formulations. J. Pharm. Sci. 87 (1998) 678-683
7. Plank C., et al. Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. Hum. Gene Ther. 10 (1999) 319-332
8. Adami R.C., and Rice K.G. Metabolic stability of glutaraldehyde cross-linked peptide-DNA condensates. J. Pharm. Sci. 88 (1999) 739-746
9. Mckenzie D.L., et al. Low molecular weight disulphide cross-linking peptides as non-viral gene delivery carriers. Bioconjugate Chem. 11 (2000) 901-909
10. Kwok K.Y., et al. In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates. J. Pharm. Sci. 92 (2003) 1174-1183
11. Read M.L., et al. Vectors based on reducible polycations facilitate intracellular release of nucleic acids. J. Gene Med. 5 (2003) 232-245
12. Oupicky D., et al. Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of the DNA delivery vectors. J. Am. Chem. Soc. 124 (2002) 8-9
13. Schwarze S.R., and Dowdy S.F. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21 (2000) 45-48
14. Trehin R., and Merkle H.P. Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur. J. Pharmaceut. Biopharmaceut. 58 (2004) 209-223
15. Futaki S. Oligoarginine vectors for intracellular delivery: design and cellular uptake mechanisms. Biopolymers 84 (2006) 241-249
16. Futaki S., et al. Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276 (2001) 5836-5840
17. Suzuki T., et al. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277 (2002) 2437-2443
18. Rothbard J.B., et al. Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J. Med. Chem. 45 (2002) 3612-3618
19. Futaki S., et al. Translocation of branched chain arginine peptides through cell membranes: flexibility in the disposition of positive charges in membrane permeable peptides. Biochemistry 41 (2002) 7925-7930
20. Mitchell D.J., et al. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Peptide Res. 56 (2000) 318-325
21. Wender P.A., et al. The design, synthesis and evaluation of molecules that enable or enhance peptoid molecular transporters. Proc. Natl. Acad. Sci. 97 (2000) 13003-13008
22. Oehlke J., et al. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytotically. Biochim. Biophys. Acta 1414 (1998) 127-139
23. Scheller A., et al. Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J. Peptide Sci. 5 (1999) 185-194
24. Gait M.J., et al. Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues. Cell. Mol. Life Sci. 60 (2003) 844-853
25. Koppelhus U., et al. Cellular delivery of peptide nucleic acids. Adv. Drug Deliv. Rev. 55 (2003) 267-280
26. Eguchi, et al. Protein transduction domain of HIV TAT protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 276 (2001) 26204-26210
27. Zorko M., and Langel U. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug Deliv. Rev. 57 (2005) 529-545
28. Shiraishi T., et al. Enhanced delivery of cell penetrating peptide-peptide nucleic acid conjugates by endosomal disruption. Nat. Protoc. 1 (2006) 633-636
29. 6-penetratin delivery peptide. Nucl. Acids Res. 35 (2007) 4495-4502
30. Wu R.P., et al. Cell penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity. Nucl. Acids Res. 35 (2007) 5182-5191
31. Kim H.H., et al. Characterization of gene delivery in vitro and in vivo by the arginine peptide system. Intl. J. Pharmaceut. 335 (2006) 70-78
32. Rudolph C., et al. Oligomers of the arginine-rich motif of the HIV-TAT protein are capable of transferring plasmid DNA into cells. J. Biol. Chem. 278 (2003) 11411-11418
33. Liu Z., et al. Macro-branched cell-penetrating peptide design for gene delivery. J. Control. Rel. 102 (2005) 699-710
34. Futaki S., et al. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjugate Chem. 12 (2001) 1005-1011
35. van Rossenberg S.M.W., et al. Stable polyplexes based on arginine-containing oligopeptides for in vivo gene delivery. Gene Ther. 11 (2004) 457-464
36. Siprashvili Z., et al. Gene transfer via reversible plasmid condensation with cysteine flanked, internally spaced arginine-rich peptides. Hum. Gene Therapy 14 (2003) 1225-1233
37. Meade B.R., et al. Exogenous si-RNA delivery using peptide transduction domains/cell penetrating peptides. Adv. Drug Deliv. Rev. 59 (2007) 134-140
38. Richard J.P., et al. Cell-penetrating peptides. A re-evaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
39. Kaplan I.M., et al. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Control. Rel. 102 (2005) 247-253
40. Nakase I., et al. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol. Ther. 10 (2004) 1011-1022
41. Patel, et al. Cell penetrating peptide: Intracellular pathways and pharmaceutical perspectives. Pharm. Res. 24 (2007) 1977-1992
42. Wagner E. Application of membrane-active peptides for non-viral gene delivery. Adv. Drug Deliv. Rev. 38 (1999) 279-289
43. Wyman T.B., et al. Design, synthesis and characterization of a cationic peptide that binds to nucleic acids and permeates bilayers. Biochemistry 36 (1997) 3008-3017
44. Rittner K., et al. New basic membrane-destabilizing peptides for plasmid based gene delivery in vitro and in vivo. Mol. Ther. 5 (2002) 104-114
45. Lindgren M.E., et al. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro. Biochem. J. 377 (2004) 69-76
46. Wagner E., et al. Influenza virus hemagglutinin HA-2N terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene transfer vehicle. Proc. Natl. Acad. Sci. 89 (1992) 7934-7938
47. Parker A.L., et al. (Lys)16-based reducible polycations provide stable polyplexes with anionic fusogenic peptides and efficient gene delivery to post-mitotic cells. Biochim. Biophys. Acta 1770 (2007) 1331-1337
48. Midoux P., et al. Membrane permeabilization and efficient gene transfer by a peptide containing several histidines. Bioconjugate Chem. 9 (1998) 260-267
49. Pichon C., et al. Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides. Nucl. Acids Res. 28 (2000) 504-512
50. Chen Q.R., et al. Branched co-polymers of histidine and lysine are efficient carriers of plasmid. Nucl. Acids Res. 29 (2001) 1334-1340
51. Leng Q., et al. A branched histidine/lysine peptide, H2K4b, in complex with plasmids encoding antitumor proteins inhibits tumor xenografts. J. Gene Med. 8 (2006) 1407-1415
52. Manickam D.S., et al. Multiblock reducible copolypeptides containing histidine-rich and nuclear localization sequences for gene delivery. Bioconjugate Chem. 17 (2006) 1395-1403
53. Kichler A., et al. Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc. Natl. Acad. Sci. 100 (2003) 1564-1568
54. Mason A.J., et al. Optimising histidine-rich peptides for efficient DNA delivery in the presence of serum. J. Control. Rel. 118 (2007) 95-104
55. Escriou V., et al. NLS bioconjugates for targeting therapeutic genes to the nucleus. Adv. Drug Deliv. Rev. 55 (2003) 295-306
56. Akita H., et al. Evaluation of the nuclear delivery and intra-nuclear transcription of plasmid DNA condensed with mu and NLS-mu by cytoplasmic and nuclear microinjection: a comparative study with poly-l-lysine. J. Gene Med. 8 (2006) 198-206
57. Zanta M.A., et al. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. 86 (1999) 91-96
58. Ludtke J.J., et al. A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. J. Cell Sci. 112 (1999) 2033-2041
59. Neves C., et al. Coupling of a targeting peptide to plasmid DNA by covalent triple helix formation. FEBS Lett. 453 (1999) 41-45
60. Roulon T., et al. Coupling of a targeting peptide to plasmid DNA using a new type of padlock oligonucleotide. Bioconjugate Chem. 13 (2002) 1134-1139
61. Bremmer K.H., et al. Factors influencing the ability of nuclear localization sequence peptides to enhance non-viral gene delivery. Bioconjugate Chem. 15 (2004) 152-161
62. Ciolina C., et al. Coupling of nuclear localization signals to plasmid DNA and specific interaction of the conjugates with importin-alpha. Bioconjugate Chem. 10 (1999) 49-55
63. Morris M.C., et al. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucl. Acids Res. 25 (1997) 2730-2736